Itai Danovitch

3.3k total citations · 1 hit paper
58 papers, 2.1k citations indexed

About

Itai Danovitch is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Epidemiology. According to data from OpenAlex, Itai Danovitch has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 18 papers in Pharmacology and 13 papers in Epidemiology. Recurrent topics in Itai Danovitch's work include Opioid Use Disorder Treatment (13 papers), Treatment of Major Depression (10 papers) and Substance Abuse Treatment and Outcomes (8 papers). Itai Danovitch is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Treatment of Major Depression (10 papers) and Substance Abuse Treatment and Outcomes (8 papers). Itai Danovitch collaborates with scholars based in United States, South Korea and Brazil. Itai Danovitch's co-authors include Waguih William IsHak, Brennan Spiegel, Matthew Goldenberg, Mark W. Reid, Bradley T. Rosen, David A. Gorelick, Brigitte Vanle, Sameer Hassamal, Brandon Birckhead and Kim Bullock and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and BMJ.

In The Last Decade

Itai Danovitch

56 papers receiving 2.0k citations

Hit Papers

Pain and Depression: A Systematic Review 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pain and Depression: A Systematic Review
    2018 294 citations Waguih William IsHak, Brigitte Vanle et al. profile →

Peers

Itai Danovitch
Alejandro Salazar Spain
Maureen J. Simmonds United States
Marco Stramba‐Badiale Italy
Jessica M. Ketchum United States
Braden Kuo United States
Masahiko Sumitani Japan
Mei‐Hua Huang United States
Carol A. Landis United States
Kyle Vader Canada
Beth D. Darnall United States
Alejandro Salazar Spain
Itai Danovitch
Citations per year, relative to Itai Danovitch Itai Danovitch (= 1×) peers Alejandro Salazar

Countries citing papers authored by Itai Danovitch

Since Specialization
Citations

This map shows the geographic impact of Itai Danovitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itai Danovitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itai Danovitch more than expected).

Fields of papers citing papers by Itai Danovitch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itai Danovitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itai Danovitch. The network helps show where Itai Danovitch may publish in the future.

Co-authorship network of co-authors of Itai Danovitch

This figure shows the co-authorship network connecting the top 25 collaborators of Itai Danovitch. A scholar is included among the top collaborators of Itai Danovitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itai Danovitch. Itai Danovitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Ashley N. D., Tiffany Chang, Omer Liran, et al.. (2025). Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008–2024). Neuroscience Applied. 4. 105507–105507. 1 indexed citations
2.
Hirsch, D J, Sarah Miles, Ashley N. D. Meyer, et al.. (2025). Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008–2024) and pipeline phase III medications. Drugs in Context. 14. 1–24. 2 indexed citations
3.
4.
Evans, Sandra K., Allison J. Ober, Ariella R. Korn, et al.. (2024). Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder. Addiction Science & Clinical Practice. 19(1). 31–31. 2 indexed citations
5.
6.
Sparrow, Nicklaus A., Mohammad H. Rashid, Eric J. Ley, et al.. (2022). Systemic interleukin-6 inhibition ameliorates acute neuropsychiatric phenotypes in a murine model of acute lung injury. Critical Care. 26(1). 274–274. 9 indexed citations
7.
Bhalla, Ish P., et al.. (2021). Involuntary Psychiatric Hospitalization: How Patient Characteristics Affect Decision-Making. Psychiatric Quarterly. 93(1). 297–310. 4 indexed citations
8.
9.
Spiegel, Brennan, Garth Fuller, Mayra Lopez, et al.. (2019). Virtual reality for management of pain in hospitalized patients: A randomized comparative effectiveness trial. PLoS ONE. 14(8). e0219115–e0219115. 144 indexed citations
10.
Danovitch, Itai, et al.. (2019). Opioid Overdose in the Hospital Setting: A Systematic Review. Journal of Addiction Medicine. 14(1). 39–47. 11 indexed citations
11.
Birckhead, Brandon, Carine Khalil, Albert Rizzo, et al.. (2018). Recommendations for Methodology of Virtual Reality Clinical Trials in Health Care by an International Working Group: Iterative Study. JMIR Mental Health. 6(1). e11973–e11973. 242 indexed citations
12.
Sumner, Lekeisha A., et al.. (2018). Psychological Interventions in Inpatient Medical Settings: A Brief Review. 4(5). 73–83. 2 indexed citations
13.
Hassamal, Sameer, Karen Miotto, William Dale, & Itai Danovitch. (2018). Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. The American Journal of Medicine. 131(11). 1382.e1–1382.e6. 96 indexed citations
14.
Vanle, Brigitte, Justin S. Miller, Mark W. Reid, et al.. (2017). Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study. The Journal of Clinical Psychiatry. 78(7). 897–903. 10 indexed citations
15.
Tashjian, Vartan C., Sasan Mosadeghi, Mayra Lopez, et al.. (2017). Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial. JMIR Mental Health. 4(1). e9–e9. 204 indexed citations
16.
Hassamal, Sameer, Matthew Goldenberg, Waguih William IsHak, et al.. (2017). Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review. Journal of Psychiatric Practice. 23(3). 221–229. 22 indexed citations
17.
Danovitch, Itai, Matthew Goldenberg, Margaret Haglund, et al.. (2016). Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders. Journal of Addiction Medicine. 11(1). 47–54. 6 indexed citations
18.
Wilkins, Jeffery N., et al.. (2012). Training the Next Generation of Providers in Addiction Medicine. Psychiatric Clinics of North America. 35(2). 461–480. 65 indexed citations
19.
Danovitch, Itai & David A. Gorelick. (2012). State of the Art Treatments for Cannabis Dependence. Psychiatric Clinics of North America. 35(2). 309–326. 76 indexed citations
20.
Danovitch, Itai. (2001). Who needs medical students?: Doctoring is as much about teaching as it is about treating. Western Journal of Medicine. 174(1). 8–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Salazar Breakdown of academic impact, for papers by Maureen J. Simmonds Breakdown of academic impact, for papers by Marco Stramba‐Badiale Breakdown of academic impact, for papers by Jessica M. Ketchum Breakdown of academic impact, for papers by Braden Kuo Breakdown of academic impact, for papers by Masahiko Sumitani Breakdown of academic impact, for papers by Mei‐Hua Huang Breakdown of academic impact, for papers by Carol A. Landis Breakdown of academic impact, for papers by Kyle Vader Breakdown of academic impact, for papers by Beth D. Darnall
Rankless by CCL
2026